Have You experienced a side effect?
and Vote

Yes, Severe
Yes, Moderate
Yes, Minor
No
Discuss Results
1.5 million people annually are harmed from drug errors. Side Effects Reported Today:

Don't Risk Your Health!
Ask a Health Expert Now


AORTIC THROMBOSIS side effect

What is AORTIC THROMBOSIS ?
Help Community - Describe Your Side Effect   Search FDA Side Effects   Ask Health Expert   AORTIC THROMBOSIS and Recently Reported Side Effects   AORTIC THROMBOSIS and 15 most Active Side Effect polls   AORTIC THROMBOSIS and featured health surveys   Substances toxic to Health   Recent Hospital reviews   Comments about Side Effects   Hospital Quality reviews   Homecare Quality reviews
Health Expert

A Health Expert wants to answer your question.

Please provide details below.



Drugs associated with AORTIC THROMBOSIS

ACTIVASE  ARGATROBAN  ASPIRIN  AUGMENTIN  AVONEX  BLEOMYCIN  BORTEZOMIB  CISPLATIN  ENOXAPARIN  EPOGEN  FLUORESCITE  FLUOROURACIL  MEMANTINE  NOVOSEVEN  TAXOTERE  TRASYLOL  VELCADE  


Bortezomib Side Effects Report #5677214-6
Health Professional from UNITED STATES reported BORTEZOMIB problem on Mar 21, 2008. Male patient, weighting 143.3 lb, was diagnosed with lung neoplasm malignant and was treated with BORTEZOMIB. After drug was administered, patient experienced the following problems/side effects: aortic thrombosis, platelet count increased, . BORTEZOMIB dosage: 2.8 MG WK 1 + 2 OF 3 WKS IV BOLUS. During the same period patient was treated with BEVACIZUMAB, ASPIRIN, NEXIUM, COUMADIN, ZOFRAN, SPIRIVA, MIRACLE MOUTHWASH, ADVAIR DISKUS. Patient was hospitalized. Patient recovered.

Taxotere Side Effects Report #5637292-7
TAXOTERE problem was reported by a Physician from NORWAY on Feb 17, 2008. Male patient, 66 years of age, was diagnosed with neoplasm malignant and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: aortic thrombosis, . TAXOTERE dosage: unknown. During the same period patient was treated with CISPLATIN, FLUOROURACIL. Patient recovered.

Taxotere Side Effects Report #5645510-4
Physician from NORWAY reported TAXOTERE problem on Feb 22, 2008. Male patient, 66 years of age, was diagnosed with prophylaxis, nausea and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: aortic thrombosis, compartment syndrome, leriche syndrome, monoparesis, nephropathy, rhabdomyolysis, . TAXOTERE dosage: unknown. During the same period patient was treated with CISPLATIN, FLUOROURACIL, CIPROXIN, ZOFRAN, EMEND, AFIPRAN. Patient was hospitalized. Patient recovered.

Novoseven Side Effects Report #5601010-9
NOVOSEVEN problem was reported by a Physician from UNITED STATES on Jan 17, 2008. Female patient was diagnosed with haemorrhage and was treated with NOVOSEVEN. After drug was administered, patient experienced the following problems/side effects: aortic thrombosis, intracardiac thrombus, thrombosis in device, . NOVOSEVEN dosage: unknown. During the same period patient was treated with HEPARIN. Patient died on 06/08/2006.


Aspirin Side Effects Report #5558643-8
Consumer or non-health professional from reported ASPIRIN problem on Dec 10, 2007. Female patient was treated with ASPIRIN. After drug was administered, patient experienced the following problems/side effects: aortic thrombosis, embolism, gastrointestinal haemorrhage, haemolysis, ventricular arrhythmia, ventricular fibrillation, . ASPIRIN dosage: 81 MG - 100 MG. During the same period patient was treated with DIPYRIDAMOLE, WARFARIN, HEPARIN. Patient died.

Novoseven Side Effects Report #5519163-X
NOVOSEVEN problem was reported by a Physician from UNITED STATES on Nov 14, 2007. Female patient was diagnosed with haemorrhage and was treated with NOVOSEVEN. After drug was administered, patient experienced the following problems/side effects: aortic thrombosis, intracardiac thrombus, thrombosis in device, . NOVOSEVEN dosage: unknown. Patient died.

Argatroban Side Effects Report #5448597-7
Physician from UNITED STATES reported ARGATROBAN problem on Aug 21, 2007. Female patient, weighting 10.36 lb, was diagnosed with heparin-induced thrombocytopenia and was treated with ARGATROBAN. After drug was administered, patient experienced the following problems/side effects: aortic thrombosis, embolism, extremity necrosis, hypotension, labile blood pressure, lactic acidosis, vena cava thrombosis, . ARGATROBAN dosage: unknown. During the same period patient was treated with HEPARIN, RED BLOOD CELLS, PLASMA, CRYOPRECIPITATE INFUSIONS. Patient died.

Cisplatin Side Effects Report #5420234-7
CISPLATIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 06, 2007. Male patient, 42 years of age, was diagnosed with oesophageal adenocarcinoma and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: aortic thrombosis, haemodialysis, haemoglobin decreased, iliac artery embolism, intestinal infarction, intracardiac thrombus, left ventricular dysfunction, mesenteric artery embolism, . CISPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL. Patient was hospitalized. Patient died.

Fluorescite Side Effects Report #5423139-0
Consumer or non-health professional from JAPAN reported FLUORESCITE problem on Aug 06, 2007. Male patient, 72 years of age, was diagnosed with angiogram retina and was treated with FLUORESCITE. After drug was administered, patient experienced the following problems/side effects: aortic thrombosis, cerebral artery embolism, hyperhidrosis, loss of consciousness, syncope, syncope vasovagal, . FLUORESCITE dosage: 5.0 ML IV OVER 15 SEC INTRAVENOUS. During the same period patient was treated with TROPICAMIDE, PHENYLEPHRINE, METOCLOPRAMIDE, KALLIDINOGENASE, PIRENOXINE, LEVOCABASTINE HYDROCHLORIDE, HERBAL PREPARATION. Patient recovered.


Cisplatin Side Effects Report #5400224-0
CISPLATIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on July 11, 2007. Female patient, 71 years of age, was diagnosed with oesophageal adenocarcinoma and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: aortic thrombosis, renal infarct, splenic infarction, . CISPLATIN dosage: unknown. Patient was hospitalized. Patient recovered.

Cisplatin Side Effects Report #5400224-0
Consumer or non-health professional from UNITED KINGDOM reported CISPLATIN problem on July 11, 2007. Female patient, 71 years of age, was diagnosed with oesophageal adenocarcinoma and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: aortic thrombosis, renal infarct, splenic infarction, . CISPLATIN dosage: unknown. Patient was hospitalized. Patient recovered.

Enoxaparin Side Effects Report #5727423-2
ENOXAPARIN problem was reported by a Consumer or non-health professional from GERMANY on Apr 29, 2008. Male patient, 47 years of age, weighting 194.0 lb, was diagnosed with thrombosis prophylaxis and was treated with ENOXAPARIN. After drug was administered, patient experienced the following problems/side effects: aortic thrombosis, atrial thrombosis, compartment syndrome, heparin-induced thrombocytopenia, peroneal nerve palsy, pulmonary embolism, . ENOXAPARIN dosage: unknown. During the same period patient was treated with HEPARIN. Patient was hospitalized. Patient recovered.

Augmentin Side Effects Report #5697713-0
Physician from FRANCE reported AUGMENTIN problem on Mar 28, 2008. Male patient, 61 years of age, weighting 147.7 lb, was diagnosed with post procedural infection and was treated with AUGMENTIN. After drug was administered, patient experienced the following problems/side effects: aortic thrombosis, calculus bladder, cholestasis, fluid retention, haemangioma, jaundice, renal cyst, . AUGMENTIN dosage: unknown. During the same period patient was treated with HUMEX, LERCAN, DETENSIEL, KARDEGIC, FLECAINIDE ACETATE, ELISOR, COAPROVEL. Patient recovered.

Activase Side Effects Report #5705148-7
ACTIVASE problem was reported by a Health Professional from GERMANY on Apr 09, 2008. Male patient, 61 years of age, was diagnosed with myocardial infarction and was treated with ACTIVASE. After drug was administered, patient experienced the following problems/side effects: aortic thrombosis, intracardiac thrombus, renal impairment, . ACTIVASE dosage: unknown. Patient was hospitalized. Patient recovered.


Trasylol Side Effects Report #5309563-5
Physician from UNITED STATES reported TRASYLOL problem on Apr 25, 2007. Female patient, 58 years of age, was diagnosed with coronary artery bypass and was treated with TRASYLOL. After drug was administered, patient experienced the following problems/side effects: aortic thrombosis, electrocardiogram st segment elevation, graft thrombosis, hypotension, intracardiac thrombus, . TRASYLOL dosage: unknown. During the same period patient was treated with PROTAMINE SULPHATE, PLAVIX, HEPARIN, ACE INHIBITORS, NOREPINEPHRINE BITARTRATE. Patient died on 02/06/2007.

Velcade Side Effects Report #5531307-2
VELCADE problem was reported by a Physician from JAPAN on Nov 12, 2007. Male patient, 80 years of age, weighting 110.2 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: aortic arteriosclerosis, aortic thrombosis, atrophy, bone marrow failure, bronchopneumonia, cardio-respiratory arrest, decreased appetite, electrocardiogram qt prolonged, excessive granulation tissue, . VELCADE dosage: 1.30 MG/M2. During the same period patient was treated with LAFUTIDINE, SELBEX, DIFLUCAN, ALENDRONATE, ROHYPNOL, BAKTAR, HEPARIN. Patient died on 01/08/2007.

Epogen Side Effects Report #5480492-X
Consumer or non-health professional from UNITED STATES reported EPOGEN problem on Oct 04, 2007. Male patient, 64 years of age, weighting 208.0 lb, was diagnosed with anaemia and was treated with EPOGEN. After drug was administered, patient experienced the following problems/side effects: anaemia, aortic thrombosis, cardiac failure congestive, cerebrovascular accident, confusional state, gastrointestinal haemorrhage, mental impairment, nervous system disorder, . EPOGEN dosage: unknown. During the same period patient was treated with ERYTHROPOIETIN. Patient died on 03/11/2007.

Memantine Side Effects Report #5505165-6
MEMANTINE problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 24, 2007. Female patient, 70 years of age, weighting 170.6 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: anoxic encephalopathy, aortic thrombosis, aspiration, blood glucose increased, blood phosphorus increased, bronchopneumonia, cardiac arrest, cardio-respiratory arrest, cerebellar atrophy, . MEMANTINE dosage: 28 MG QD;PO. During the same period patient was treated with ARICEPT, CALTRATE, CELEXA, FOLBIC, VATAMINS, PLAQUENIL, VITAMIN E. Patient was hospitalized. Patient died on 07/18/2007.

Cisplatin Side Effects Report #5412708-X
Consumer or non-health professional from UNITED KINGDOM reported CISPLATIN problem on July 25, 2007. Male patient, 42 years of age, was diagnosed with oesophageal adenocarcinoma and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: acute abdomen, aortic thrombosis, asthenia, haemodialysis, intestinal infarction, intracardiac thrombus, pain in extremity, post procedural complication, renal failure acute, . CISPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL. Patient was hospitalized. Patient died.


Cisplatin Side Effects Report #5397325-2
CISPLATIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on July 06, 2007. Male patient, 42 years of age, was diagnosed with oesophageal adenocarcinoma and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: acute abdomen, aortic thrombosis, asthenia, haemodialysis, intestinal infarction, intracardiac thrombus, pain in extremity, paraesthesia, post procedural complication, . CISPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL. Patient was hospitalized. Patient died.

Cisplatin Side Effects Report #5397325-2
Consumer or non-health professional from UNITED KINGDOM reported CISPLATIN problem on July 06, 2007. Male patient, 42 years of age, was diagnosed with oesophageal adenocarcinoma and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: acute abdomen, aortic thrombosis, asthenia, haemodialysis, intestinal infarction, intracardiac thrombus, pain in extremity, paraesthesia, post procedural complication, . CISPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL. Patient was hospitalized. Patient died.

Avonex Side Effects Report #5772451-4
AVONEX problem was reported by a Physician from UNITED STATES on May 30, 2008. Female patient, 53 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: angiopathy, aortic thrombosis, arterial thrombosis, arteriosclerosis, dialysis, disorientation, leg amputation, pneumonia, renal failure, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.

Avonex Side Effects Report #5751880-9
Physician from UNITED STATES reported AVONEX problem on May 12, 2008. Female patient, 53 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: angiopathy, aortic thrombosis, dialysis, disorientation, iliac artery thrombosis, ischaemia, leg amputation, pneumonia, renal failure, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.

Fluorouracil Side Effects Report #5279898-3
FLUOROURACIL problem was reported by a Physician from SWITZERLAND on Mar 15, 2007. Male patient, 57 years of age, was diagnosed with rectal cancer metastatic and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: aortic embolus, aortic thrombosis, . FLUOROURACIL dosage: 500 MG/M2, 1/WEEK X 4, INTRAVENOUS. During the same period patient was treated with IRINOTECAN, BEVACIZUMAB, LEUCOVORIN CALCIUM. Patient recovered.

Bleomycin Side Effects Report #5689815-X
Consumer or non-health professional from FRANCE reported BLEOMYCIN SULPHATE problem on Mar 05, 2008. Male patient, 26 years of age, was diagnosed with testis cancer and was treated with BLEOMYCIN SULPHATE. After drug was administered, patient experienced the following problems/side effects: akinesia, aortic occlusion, aortic thrombosis, ejection fraction decreased, hyperkinesia, necrosis, . BLEOMYCIN SULPHATE dosage: 30 MG. During the same period patient was treated with ETOPOSIDE, CISPLATIN. Patient recovered.

PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.


Thank you for visiting Patientsville.com. We hope you found our information about AORTIC THROMBOSIS side effects helpful. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting Patientsville.net. Hope you enjoyed finding information on medications and found answers to Your Questions about AORTIC THROMBOSIS